chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cold; chills; body aches; my are (arm) was sore at the injection site; I had a not the size of a quarter on my right arm; I had a not the size of a quarter on my right arm / painful; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 05Nov2021 15:45 (Batch/Lot number: unknown) at the age of 47 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing); "Factor V" (unspecified if ongoing); "Knee problems" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: NAPROXEN; OMEPRAZOLE; PROPRANOLOL. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6205, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 02Mar2021, when the patient was 47 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EM9809, Location of injection: Arm Right, Vaccine Administration Time: 03:00 PM), administration date: 04Feb2021, when the patient was 46 years old, for COVID-19 immunization. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 06Nov2021 13:30, outcome "not recovered", described as "cold"; CHILLS (non-serious) with onset 06Nov2021 13:30, outcome "not recovered", described as "chills"; PAIN (non-serious) with onset 06Nov2021 13:30, outcome "not recovered", described as "body aches"; VACCINATION SITE PAIN (non-serious) with onset 06Nov2021 13:30, outcome "not recovered", described as "my are (arm) was sore at the injection site"; MASS (non-serious) with onset 06Nov2021 13:30, outcome "not recovered", described as "I had a not the size of a quarter on my right arm"; PAIN (non-serious) with onset 06Nov2021 13:30, outcome "not recovered", described as "I had a not the size of a quarter on my right arm / painful". The events "cold", "chills", "body aches", "my are (arm) was sore at the injection site", "i had a not the size of a quarter on my right arm" and "i had a not the size of a quarter on my right arm / painful" were evaluated at the physician office visit. Therapeutic measures were taken as a result of nasopharyngitis, chills, pain, vaccination site pain, mass, pain.   Additional Information: No Covid prior vaccination, nor tested post vaccination. Adverse events resulted in: Doctor or other healthcare professional office/clinic visit.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Injection site hot after 2nd dose; Looks like he got punched in the arm after 2nd dose; Pain; Soreness; Huge red spot under where he had shot after 2nd dose; Injection site swollen after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot after 2nd dose), LIMB DISCOMFORT (Looks like he got punched in the arm after 2nd dose), PAIN (Pain), PAIN IN EXTREMITY (Soreness) and VACCINATION SITE ERYTHEMA (Huge red spot under where he had shot after 2nd dose) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001c21a and 003b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site hot after 2nd dose), LIMB DISCOMFORT (Looks like he got punched in the arm after 2nd dose), PAIN (Pain), PAIN IN EXTREMITY (Soreness), VACCINATION SITE ERYTHEMA (Huge red spot under where he had shot after 2nd dose) and VACCINATION SITE SWELLING (Injection site swollen after 2nd dose). At the time of the report, VACCINATION SITE WARMTH (Injection site hot after 2nd dose), LIMB DISCOMFORT (Looks like he got punched in the arm after 2nd dose), PAIN (Pain), PAIN IN EXTREMITY (Soreness), VACCINATION SITE ERYTHEMA (Huge red spot under where he had shot after 2nd dose) and VACCINATION SITE SWELLING (Injection site swollen after 2nd dose) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.   Patient took Anthax vaccine and experienced soreness and redspot.  Action taken in response to mRNA-1273 was considered to be not applicable.   This case was linked to MOD-2021-097969 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow up was received on 01-June-2021 and patient demographics and two events ( pain and pain in extremity ) were updated.
Water in eyes; It feels like a vise squeezing the base of his neck; Blurred vision; Severe headache on the right side of the back of his head down into his brain stem with all 3 doses/ extreme headaches with all 3 doses; Back trouble after all 3 doses; Prostate problems of aching in the rectum area after the 2nd dose & booster dose; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back trouble after all 3 doses), PROCTALGIA (Prostate problems of aching in the rectum area after the 2nd dose & booster dose), LACRIMATION INCREASED (Water in eyes), FEELING ABNORMAL (It feels like a vise squeezing the base of his neck) and VISION BLURRED (Blurred vision) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Back discomfort, Prostate infection (when he was 35), Bladder infection (when he was 35) and Rectal pain (when he was 35).   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back trouble after all 3 doses), PROCTALGIA (Prostate problems of aching in the rectum area after the 2nd dose & booster dose), LACRIMATION INCREASED (Water in eyes), FEELING ABNORMAL (It feels like a vise squeezing the base of his neck), VISION BLURRED (Blurred vision) and HEADACHE (Severe headache on the right side of the back of his head down into his brain stem with all 3 doses/ extreme headaches with all 3 doses). At the time of the report, BACK PAIN (Back trouble after all 3 doses), PROCTALGIA (Prostate problems of aching in the rectum area after the 2nd dose & booster dose), LACRIMATION INCREASED (Water in eyes), FEELING ABNORMAL (It feels like a vise squeezing the base of his neck), VISION BLURRED (Blurred vision) and HEADACHE (Severe headache on the right side of the back of his head down into his brain stem with all 3 doses/ extreme headaches with all 3 doses) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Prostatic specific antigen: 6 (abnormal) PSA was 6. In April 2021, X-ray: abnormal (abnormal) Something on his x-ray on the right side of his back. In 2021, Magnetic resonance imaging: abnormal (abnormal) Bone spurs on right hand side & a little something on prostate.. In 2021, Prostatic specific antigen: 4.5 (abnormal) 4.5 when he saw his urologist in August or September of 2021..         He had the same prostate trouble when he was 35 but has not had it since.  About 2 or 3 weeks after the 2nd dose he began having the back and prostate trouble.  Treatment information includes sitting in hot water helps the rectum aching.  No concomitant medications were reported.   This case was linked to MOD-2021-416057, MOD-2021-035354 (Patient Link).
chest pain; chest pressure; very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), CHEST DISCOMFORT (chest pressure) and PAIN IN EXTREMITY (very sore arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced CHEST PAIN (chest pain), CHEST DISCOMFORT (chest pressure) and PAIN IN EXTREMITY (very sore arm). On 15-Aug-2021, CHEST PAIN (chest pain), CHEST DISCOMFORT (chest pressure) and PAIN IN EXTREMITY (very sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. The patient experienced sore arm, chest pain, and chest pressure four hours after the first dose, chest pain and pressure never lasted more than a minute and continued to happen off and on that weekend. The symptoms resolved after Sunday,15-Aug-2021. She did not take any treatment  to help with the symptoms.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On 08-OCT-2014, unspecified amount patients were vaccinated with RECOMBIVAX HB lot # reported as J014855, expiry date 16-APR-2016 (dose, route of administration, were not reported) that were improperly stored. No adverse symptom was reported. It was reported that the temperature excursion was unsupported with in-house stability data. This is one of several reports received from the same reporter. Additional information has been requested.
3:00 rt arm swollen to fingertips;9NOV arm discolored, painful;cannot move easily;pt tired-10NOV situation starting to resolve;
Slight fever; body aches; This is a spontaneous report from a contactable consumer. A 67-years-old male patient received bnt162b2, dose 1 via an unspecified route of administration on 25Jan2021 at 4:00 pm (Batch/Lot Number: EL9267) as single dose for COVID-19 immunisation.  The patient medical history and concomitant medication was not reported. On 28Jan2021 at 01:00 AM the patient experienced slight fever and body aches several days after administration increasing in severity for the following week. Body aches, fever of 101.5. Symptoms lasted a week. Similar experience after vaccine 2. On 15Feb2021, Nasal swab covid test was done. The result was negative. No known allergies reported for patient. Over the counter analgesics was administered for treatment. The outcome of the events was Recovering.
9 days after the injection, a warm red patch developed on my right arm just under the vaccine site. It is about the size of a 50-cent piece.
2-4 cm x2cm red erythematous macular on back of rt arm, 1-4x4cm red erythematous macular on back of L arm-warm to touch painful.
1) Immune disfunction 2) Asthma 3) Allergy 4) Eczema 5) Mercury poisoning 6) Developmental delays 7) Colitis 8) Autism  Shortly after the administration of my son's first vaccines he exhibited symptoms of asthma and allergy. By the time he was 10 months old we became aware that he was missing cognitive and communication developmental milestones. At age 15 months he was evaluated by a clinical pyschologist who described by son as having symptoms consistent with autism. This was confirmed with a diagnosis of PDD-NOS by a pediatric neurologist a age 19 months. In the mean time my son developed severe ezcema over about 1/3 of his body. At age 22 months my son began receiveing treatment for allergy, asthma and other immune disfunctions. At age 24 months a colonscopy revealed colitis in my son's large and small intestine. At approximately 30 months a urinalysis revealed extremely high levels o merucry and other metals in my son's urine. Periodic urinalysis since then have shown consistently high level of mercury and other metals.  At age 38 months my son was evaluated by a clinical pyscologist and given a diagnosis of autism.
NO APPARENT ADVERSE REACTION, BIVALENT VACCINE ADMINISTERED FOR DOSE 1 INSTEAD OF MONOVALENT VACCINE.
after slight headache and fatigue for the first 2 days after injection, I felt OK but the third day, early AM I had some diarrhea and dizziness with nausea and headache throughout the next 2 days and I was very tired, achy and headache returned. This was followed by 3 more days of fatigue with slight headache. This is the 7th day and I am feeling somewhat better but still tired. I hope this is the last of it.
RECIEVED VACCINE, WITHIN 6 HOURS BEGAN VOMITTING AND HAVING A HEADACHE AND WITHIN 10 HOURS OF VACCINE REPORTED WORST HEADACHE OF HER LIFE AND WENT TO THE ER.  HAD A SEIZURE 24 HOURS POST VACCINE.
Initially headache  10/2/2021, next day fatigue and headache, 10/4 - flare of MS symptoms which included severe fatigue, 0n 10/6/21 as a result of excessive fatigue had a fall resulting in head injury and concussion.  12/8/2021 continue to have post concussion symptoms - brain fog, short term memory issues, headache and episodic dizziness.
never came back for 2nd shot; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 11th November 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient got the 1st shot of Shingrix and never came back for 2nd shot., which led to incomplete course of vaccination. The reporter asked, did the patient need to start all over again. The reporter consented to follow up.
06/10/2022 That evening I had a scratchy throat with increased awareness since my  husband had tested positive for COVID.  I tested positive and began taking Paxlovid on 6/11/2022. By 6/16/2022 I tested negative. I had no symptoms until 06/22/2022. My husband tested positive again, so I took a test and was positive for COVID. On 6/23/2022 I tested again at home and was positive. I began sneezing and had a runny nose and felt fine. I saw my doctor yesterday and he told me not to worry about the positive tests since it had been 2 weeks since last test.  Later that day I began feeling crappy, had clear mucous, a lot more sneezing . I took a decongestant, used my inhaler and went to bed. I had no fever. This morning when I woke up, I felt worse. I am using my inhaler. I consulted with my doctor this morning. He is going to have me do a chest x-ray tomorrow if I am not better. Otherwise, I am monitoring my peak flow and it is staying in the normal range for me.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 03-JUL-2014 the patient was vaccinated with first dose of VAQTA 50/1.0 U/ml, dose: 1 ml, intramuscularly. On 23-SEP-2014, the patient was administered the second dose of VAQTA on 23-SEP-2014. No adverse effect reported. Additional information has been requested.
About one minute after the vaccination, patient stated he was "a little light headed". A few seconds after this, he passed out. Patient regained consciousness after about 5-10 seconds. Paramedics were not contacted. Patient stayed for 25 minutes following the adverse reaction.
pt. experiencing lightheadedness.  pt. denies any difficulty swallowing &/or any other s/s.  Resolved w/ calming / comfort measure.
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with the improperly stored doses of VARIVAX (strength, dose number, route, anatomical location, lot number and expiration date were not provided). This is one of several reports received from the same source. Additional information has been requested.
Patient developed a fever and c/o body aches and pain at the injection site after receiving pneumococcal vaccine.
Pt was admitted to hospital with symptoms of congestive heart failure. Pt was normally in excellent health. Cardiologist's diagnosis was active viral myocarditis.
Pt recd vax 21APR91 & 24MAY91; p/each dose exp'd flu-like symptoms, pain @ inject site, & stiff muscles; rx: NSAIDs & antipyretics; events resolved;
This case was reported by a nurse via sales rep and described the occurrence of erythema of extremities in a female patient who received SHINGRIX for prophylaxis. In July 2018, the patient received the 1st dose of SHINGRIX. In July 2018, less than a week after receiving SHINGRIX, the patient experienced erythema of extremities, skin warm, pain in arm and itchy upper limbs. On an unknown date, the outcome of the erythema of extremities was unknown and the outcome of the skin warm and pain in arm were recovered/resolved and the outcome of the itchy upper limbs was not recovered/not resolved. It was unknown if the reporter considered the erythema of extremities, skin warm, pain in arm and itchy upper limbs to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received the SHINGRIX vaccine 5 days prior to the day of reporting. The patient had a local reaction which was described as arm was red, warm and very tender. At the time of reporting, the patient's arm was no longer sore or hot but still itched. The patient was fine and had seen worse but worried about the 2nd dose reaction. The reporter did not agree to be contacted for follow up.
Approx 3 min p/vax pt became unresponsive, limp, sweaty & pale but maintained a HR of 60-80 - nl resp & BP 90/70;
Pain and stiffness in back of head on the left side; Pain and stiffness in back of head on the left side; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 08Mar2021 at 17:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included short-bowel syndrome. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Mar2021 at 17:30, the patient experienced pain and stiffness in back of head on the left side. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain and stiffness in back of head on the left side was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
an 87 year old male with ESRD on PD, pAfib, CAD, HTN, HLD, hypothyroidism, who was brought in after a witness cardiac arrest.    Patient apparently received the first dose of the Covid vaccine (pfizer) at around 11 am. He was doing fine the rest of the day until later in the evening when he had shortness of breath without chest pain, abdominal pain, nausea, vomiting.    Upon EMS arrival, the patient appeared to have some agonal breathing and then went down, was in PEA arrest, received CPR with 1 dose of calcium, 1 dose of bicarbonate, and 3 doses of epinephrine with return of spontaneous circulation.    Upon arrival in the ED, patient had an intraosseous line, on dopamine for soft blood pressure. Patient has been successfully intubated.
pt recv vax 21OCT97 & on 3NOV97 pt exp a localized rxn of  2cm of redness;
Narrative: Dyspnea reported w/ 3rd vaccine dose. no adr recorded for prior doses.
SHAKING FROM THE HANDS; VISION SEEMED TO BE BLURRED; SPASMS IN UPPER ARM REGION; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: 04-AUG-2021) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 12-APR-2021, the subject experienced shaking from the hands. On 12-APR-2021, the subject experienced vision seemed to be blurred. On 12-APR-2021, the subject experienced spasms in upper arm region. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shaking from the hands, vision seemed to be blurred, and spasms in upper arm region. This report was non-serious.
Swelling, soreness, redness and warmness in the injection site; Swelling, soreness, redness and warmness in the injection site; Swelling, soreness, redness and warmness in the injection site; Swelling, soreness, redness and warmness in the injection site; Soreness of her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of her arm), VACCINATION SITE WARMTH (Swelling, soreness, redness and warmness in the injection site), VACCINATION SITE SWELLING (Swelling, soreness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (Swelling, soreness, redness and warmness in the injection site) and VACCINATION SITE PAIN (Swelling, soreness, redness and warmness in the injection site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003b21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of her arm). On 28-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Swelling, soreness, redness and warmness in the injection site), VACCINATION SITE SWELLING (Swelling, soreness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (Swelling, soreness, redness and warmness in the injection site) and VACCINATION SITE PAIN (Swelling, soreness, redness and warmness in the injection site). On 26-Mar-2021, PAIN IN EXTREMITY (Soreness of her arm) had resolved. At the time of the report, VACCINATION SITE WARMTH (Swelling, soreness, redness and warmness in the injection site), VACCINATION SITE SWELLING (Swelling, soreness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (Swelling, soreness, redness and warmness in the injection site) and VACCINATION SITE PAIN (Swelling, soreness, redness and warmness in the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-060735 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-060735:Son's Case
Within 2 Hrs of vaccine, pt noted extreme tenderness, and swelling of upper arm. Sx worsened over next 48 Hrs.